Finance

Lists
APLI:TSE
Appili Therapeutics Inc
CA$0.010
0.00%
(0.00) 1D
Aug 17, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for APLI...
Mkt. cap
1.32M
Avg. vol.
44.57K
Volume
0.00
52-wk high
CA$0.04
52-wk low
CA$0.01
EPS
-CA$0.03
Beta
0.18
Shares outstanding
132.37M
No. of employees
7
Mkt. cap
1.32M
Avg. vol.
44.57K
Volume
0.00
52-wk high
CA$0.04
52-wk low
CA$0.01
EPS
-CA$0.03
Beta
0.18
Shares outstanding
132.37M
No. of employees
7
News stories
From web sources and news partners
About Appili Therapeutics Inc
CEO-
Employees7
Founded2015
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
103.94K
114.98K
25.26K
117.89K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
832.83K
575.34K
1.92M
704.18K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
569.75K
256.96K
994.33K
1.03M
Operating expense
1.40M
832.29K
2.91M
1.73M
Total operating expenses
1.40M
832.29K
2.91M
1.73M
Operating income
-1.30M
-717.31K
-2.89M
-1.61M
Other non operating income
223.07K
-9.61K
3.13M
364.61K
EBT including unusual items
-954.10K
-939.68K
-1.01M
-1.69M
EBT excluding unusual items
-954.10K
-939.68K
-1.01M
-1.69M
Income tax expense
34.97K
9.82K
40.97K
7.17K
Effective tax rate
-3.66%
-1.04%
-4.06%
-0.42%
Other operating expenses
-
-
-
-
Net income
-989.06K
-949.50K
-1.05M
-1.70M
Net profit margin
-951.62%
-825.79%
-4,152.58%
-1,441.52%
Earnings per share
-
-
-
-
Interest and investment income
218.44K
-
-
-
Interest expense
-
-378.19K
-1.07M
-251.94K
Net interest expenses
218.44K
-378.19K
-1.07M
-251.94K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.30M
-715.02K
-2.89M
-1.61M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps